Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
101.69
(
1.02%
)
Bitcoin
78,519.50
(
1.16%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: cjgaddy post# 268501

Friday, 07/15/2016 6:14:07 PM

Friday, July 15, 2016 6:14:07 PM

Post# of 347009

novel exosome technology that has potential application as a simple blood test to detect or monitor cancer.



thanks CJ and I'll have to say... all I could possibly think about is this will be utilized in the medical device patent and would Peregrine and all involved want to keep this under wraps till its time? I would think so

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121701394

The deal between Peregrine/AstraZeneca and the link on the patent from Andrew Pal to ties with AstraZeneca....can't be a coincidence I'd imagine... just tossing out some puzzle pieces.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123211526

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote